SCHEMBL29567029

SCHEMBL29567029

CC(C)CCc1ccccc1-c1nc(NS(=O)(=O)c2cnn(C)c2)nc(Cl)c1C(C)(C)C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 4/20 0.35
▸ HTR7 P34969 4/20 0.35
▸ DRD2 P14416 1/20 0.32
▸ HTR6 P50406 1/20 0.32
▸ FLT4 P35916 2/20 0.32
▸ KDR P35968 2/20 0.32
▸ CNR2 P34972 1/20 0.31
▸ CYBB P04839 1/20 0.31
▸ MALT1 Q9UDY8 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ POLB P06746 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ PTPN11 Q06124 1/20 0.31
▸ KAT6A Q92794 1/20 0.31
▸ KAT5 Q92993 1/20 0.31
▸ CCNT1 O60563 3/20 0.30
▸ CCNB2 O95067 3/20 0.30
▸ CCNE2 O96020 3/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309606 1.00 HTR1A (0.35) HTR1AHTR7DRD2HTR6FLT4
SCHEMBL24309621 0.86 HTR1A (0.37) HTR1AHTR7DRD2HTR6
SCHEMBL24309547 0.85 HTR1A (0.37) HTR1AHTR7MALT1ALDH1A1PTPN11
SCHEMBL29566455 0.85 HTR1A (0.37) HTR1AHTR7MALT1ALDH1A1PTPN11
SCHEMBL24309607 0.84 HTR1A (0.37) HTR1AHTR7DRD2HTR6
SCHEMBL24310169 0.82 FLT4 (0.31) FLT4KDRCNR2
SCHEMBL24310647 0.81 HTR1A (0.33) HTR1AHTR7KDRMALT1ALDH1A1
SCHEMBL24309573 0.79 HTR1A (0.38) HTR1AHTR7KDRMALT1ALDH1A1
SCHEMBL26808526 0.79 HTR1A (0.36) HTR1AHTR7DRD2HTR6FLT4
SCHEMBL26811982 0.79 HTR1A (0.35) HTR1AHTR7DRD2HTR6FLT4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback